Please assess the completion status of the following clinical trial:

Trial Title: Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of generalized anxiety disorder (GAD)

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- active antidepressant drug comparator (Type: ACTIVE_COMPARATOR): Venlafaxine ER
- Sugar pill (Type: PLACEBO_COMPARATOR): Inert placebo pills as duble dummy - up to 4 per day for kava and 3 per day for venlafaxine
- Herbal treatment kava (Type: EXPERIMENTAL): Kava

Based on this trial design, predict the completion outcome and termination type (if applicable).